Projected Cost Savings Associated With Recombinant Tissue Plasminogen Activator Thrombolysis After Acute Ischemic Stroke From The Mexican Public Health Care System Perspective
May 1, 2014, 00:00 AM
10.1016/j.jval.2014.03.658
https://www.valueinhealthjournal.com/article/S1098-3015(14)00709-8/fulltext
Section Title :
Cardiovascular Disorders
Section Order :
89
First Page :
A113
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00709-8&doi=10.1016/j.jval.2014.03.658